- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05050266
Forbedring av mental og fysisk helse for kvinnelige veteraner (EMPOWER)
Forbedre mental og fysisk helse for kvinner gjennom engasjement og retensjon (EMPOWER) QUERI 2.0 (QUE 20-028)
Women Veterans are the fastest growing segment of VA users. This dramatic growth has created challenges for VA to ensure that appropriate services are available to meet women Veterans' needs, and that they will want and be able to use those services. The EMPOWER QUERI 2.0 Program is a cluster randomized type 3 hybrid implementation-effectiveness trial testing two strategies designed to support implementation and sustainment of evidence-based practices for women Veterans in at least 20 VA facilities from 4 regions.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Women Veterans are the fastest-growing segment of users in the Veterans Health Administration (VA). Their numbers are projected to increase by 73%, from 9.3% to 16.4%, between 2015 and 2043. Despite VA investment in improving care for women Veterans, gender disparities persist in cardiovascular (CV) and diabetes risk factor control. Also, the rate of perinatal depression among women Veterans is higher than that among civilian women, which is of particular concern given the association between perinatal depression and suicidality. Barriers to care for women Veterans include distance to VA care, rurality, competing work and caregiving responsibilities, comorbid mental health issues, and harassment on VA grounds. Improvements are still needed to increase women Veterans' access to and engagement in convenient, safe, evidence-based, patient-centered care that achieves the VA "lane of effort" of Veterans' "lifelong health, well-being, and resilience."
Since its inception in 2015, the Enhancing Mental and Physical health of Women through Engagement and Retention (EMPOWER) QUERI 1.0 team has focused on implementing gender-tailored care models for women Veteran patients. In EMPOWER 1.0 studies, women expressed preferences for gender-specific (women only) care and for virtual care options. Therefore, the EMPOWER 2.0 Impact Goal is to expand access to virtual, evidence-based, preventive lifestyle and mental health services for women Veterans with high-priority health conditions in rural and urban-isolation areas. This cluster randomized type 3 hybrid implementation-effectiveness trial randomized 20 VA sites to one of two implementation strategies, the Replicating Effective Practices (REP) or Evidence-Based Quality Improvement (EBQI), to support implementation and sustainment of evidence-based practices (EBPs). The EBPs focus on preventive lifestyle and mental health care for women Veterans across VA facilities, several of which are rural, low-performing in women's health care, and/or lead sites for high reliability organization. The study team will conduct a mixed methods implementation evaluation to compare the effectiveness of REP and EBQI in terms of: (a) improved access to and rates of engagement in virtual preventive lifestyle and mental health services and improved VA performance metrics for virtual and telehealth care delivery and related clinical outcomes for women Veterans; (b) progression along the Stages of Implementation Completion; (c) adaptation, sense-making, and experiences of EBP implementation among multilevel stakeholders; and (d) cost and return on investment.
On 8/15/23, as part of our 12 month registration update corrected the primary outcomes to accurately reflect the randomized trial and analyses design. The cluster randomized trial will evaluate the effectiveness of two implementation strategies (REP and EBQI) in implementing evidence-based practices (EBPs) for preventive services. Although we are implementing three evidence-based practices (DPP, TLC and ROSE), the EBPs are combined for each of the trial's two primary outcomes (access and engagement).
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
California
-
West Los Angeles, California, Forente stater, 90073-1003
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
This study is recruiting VA sites - not individual patients. Prior to randomization, the study team will work with sites to ensure they have met the preconditions necessary to enroll in the study, which includes VISN, regional and/or facility level leadership support for participation.
Exclusion Criteria:
N/A
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: REP
Replicating Effective Practices (REP) is a lower-intensity implementation strategy with explicit process framework for local tailoring |
The REP framework consists of 4 phases: pre-conditions, pre-implementation, implementation and maintenance/evolution. REP has a strong evidence-base and application in VHA health services research in promoting uptake of EBPs. Sites randomized to REP will meet quarterly with the implementation support team (i.e., low-intensity). |
|
Eksperimentell: EBQI
Evidence-Based Quality Improvement (EBQI) is a higher-intensity implementation strategy that entails external facilitation and formal training in quality improvement. |
EBQI is a systematic quality improvement method for engaging frontline practices in improvement that introduces "best science" and evidence in the service of operational goals. EBQI has been tested in several VA implementation trials. Sites randomized to EBQI will meet monthly with the implementation support team (i.e., high-intensity). |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Access to virtual care for preventive services
Tidsramme: 12 months
|
Proportion of eligible women Veterans who enroll in virtual DPP, TLC, or ROSE at each site |
12 months
|
|
Engagement in virtual care for preventive services
Tidsramme: 12 months
|
Proportion of eligible women Veterans who attend 1 or more virtual DPP, TLC, or ROSE sessions at each site |
12 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Participation and engagement: DPP
Tidsramme: 6 and 12 months
|
average # of sessions attended by women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: DPP
Tidsramme: 6 and 12 months
|
proportion who completed >9 and >16 sessions among women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: DPP
Tidsramme: 6 and 12 months
|
% weight change among women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: TLC
Tidsramme: 6 months
|
average # of TLC sessions completed among women Veterans who enrolled in TLC at each site |
6 months
|
|
Participation and engagement: TLC
Tidsramme: 6 months
|
% with health behavioral goal among women Veterans who enrolled in TLC at each site |
6 months
|
|
Participation and engagement: TLC
Tidsramme: 6 months
|
% with behavioral change (physical activity, diet: fruit, vegetable and sugary beverage intake, stress and coping, and weight) at each site |
6 months
|
|
Participation and engagement: ROSE
Tidsramme: 6 months
|
average # of ROSE sessions completed at each site |
6 months
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Alison B Hamilton, PhD MPH, VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Finley EP, Hamilton AB, Canelo I, Jackson SS, Lesser R, Oberman RS, Yosef J, Chrystal JG, Fletcher EH, Bean-Mayberry B, Moin T, Farmer MM, Lang AJ. Collaborative tailoring of the Reach Out, Stay Strong Essentials (ROSE) program for pregnant veterans in the U.S. Veterans Health Administration: a qualitative case study of contextual conditions and adaptations. BMC Health Serv Res. 2025 May 23;25(1):746. doi: 10.1186/s12913-025-12871-x.
- Malone A, Clair K, Chanfreau C, Bean-Mayberry B, Oberman R, Lesser R, Knight C, Finley E, Hamilton A, Farmer MM, Moin T. Predictors of enrollment in a virtual diabetes prevention program among women veterans: a retrospective analysis. BMC Womens Health. 2024 Aug 24;24(1):465. doi: 10.1186/s12905-024-03314-6.
- Finley EP, Chrystal JG, Gable AR, Fletcher EH, Palma A, Canelo I, Oberman RS, Jackson SS, Lesser R, Moin T, Bean-Mayberry B, Farmer MM, Hamilton A. The Rapid Implementation Feedback (RIF) report: real-time synthesis of qualitative data for proactive implementation planning and tailoring. Implement Sci Commun. 2024 Jun 21;5(1):69. doi: 10.1186/s43058-024-00605-9.
- Hamilton AB, Finley EP, Bean-Mayberry B, Lang A, Haskell SG, Moin T, Farmer MM; EMPOWER QUERI Team. Enhancing Mental and Physical Health of Women through Engagement and Retention (EMPOWER) 2.0 QUERI: study protocol for a cluster-randomized hybrid type 3 effectiveness-implementation trial. Implement Sci Commun. 2023 Mar 8;4(1):23. doi: 10.1186/s43058-022-00389-w.
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
- Depresjon
- Overvekt
- Mental Helse
- Kolesterol
- Hypertensjon
- Kvinner
- Sukkersyke
- Svangerskap
- Røyking
- Overvektig
- Veteraner
- Primærhelsetjenesten
- Forebygging
- Hjerte- og karsykdommer
- Pasientpreferanse
- Pasientmedvirkning
- Helseatferd
- Kvalitets forbedring
- Pasienttilfredshet
- Prediabetisk tilstand
- Leger, primærhelsetjenesten
- Risikofaktorer for hjertesykdom
- Depresjon, postpartum
- Leger, kvinner
Ytterligere relevante MeSH-vilkår
- Urogenitale sykdommer
- Sykdommer i det endokrine systemet
- Vaskulære sykdommer
- Psykiske lidelser
- Ernæringsforstyrrelser
- Kvinnelige urogenitale sykdommer og graviditetskomplikasjoner
- Metabolske sykdommer
- Overernæring
- Kroppsvekt
- Graviditetskomplikasjoner
- Atferdssymptomer
- Glukosemetabolismeforstyrrelser
- Stemningsforstyrrelser
- Puerperale lidelser
- Depressiv lidelse
- Patologiske tilstander, tegn og symptomer
- Oppførsel
- Ernæringsmessige og metabolske sykdommer
- Tegn og symptomer
- Behandlingsoverholdelse og etterlevelse
- Personlig tilfredshet
- Pasientens aksept av helsehjelp
- Overvektig
- Overvekt
- Hypertensjon
- Kardiovaskulære sykdommer
- Depresjon
- Sukkersyke
- Depresjon, postpartum
- Prediabetisk tilstand
- Psykologisk velvære
- Røyking
- Helseatferd
- Pasientmedvirkning
- Pasientpreferanse
- Pasienttilfredshet
Andre studie-ID-numre
- QUX 21-006
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Data sets underlying all publications resulting from the proposed research will not be shared outside VA, except as required under the Freedom of Information Act (FOIA), because VHA policy would prohibit re-disclosure.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .